# Neurocognitive Assessment in Adults Undergoing CD19 Targeted CAR-T Cell Therapy

> **NCT07463781** · — · NOT_YET_RECRUITING · sponsor: **Fondazione Italiana Linfomi - ETS** · enrollment: 100 (estimated)

## Conditions studied

- Diffuse Large B Cell Lymphoma (DLBCL)
- High Grade B Cell Lymphoma
- Primary Mediastinal B-cell Lymphoma (PMBCL)

## Interventions

- **OTHER:** Chimeric Antigen Receptor T-cells (CAR-T) therapy

## Key facts

- **NCT ID:** NCT07463781
- **Lead sponsor:** Fondazione Italiana Linfomi - ETS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05
- **Primary completion:** 2029-05
- **Final completion:** 2029-05
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-03-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07463781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07463781, "Neurocognitive Assessment in Adults Undergoing CD19 Targeted CAR-T Cell Therapy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07463781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*